In 1884, a 28-year-old Viennese neurologist named Sigmund Freud published a paper titled “Über Coca” — On Coca — in which he described cocaine as a substance with “the most brilliant future” and recommended it for the treatment of depression, morphine addiction, alcohol dependence, digestive disorders, and fatigue. He was not an outlier. He was, in this respect, squarely within the mainstream of contemporary medical opinion. Cocaine in the 1880s was new, exciting, and supported by what passed for clinical evidence: it made people feel dramatically better, almost immediately, every time they took it. The question of what it was doing to produce that effect, and what the cost of that effect would be over time, had not yet been seriously asked.
The arc of cocaine’s medical history is one of the sharpest in the pharmacological record: from sacred plant to miracle cure to controlled poison in the span of roughly a century, with a period of near-total medical legitimacy in the middle that is now almost impossible to imagine. To understand how a drug now synonymous with addiction and criminal enterprise was once sold in pharmacies, recommended by physicians, and enthusiastically promoted by the founding figure of modern psychology requires understanding the specific historical and scientific conditions that made it seem like a plausible medicine — and the specific mechanisms that made those conditions unsustainable.
Contents
The Coca Plant: 5,000 Years Before Cocaine
Cocaine is not an invention of the 19th century. It is a purified alkaloid extracted from the leaves of Erythroxylum coca, a shrub native to the Andean highlands that has been cultivated and used by indigenous South American peoples for at least 5,000 years and possibly considerably longer. The earliest archaeological evidence of coca use — coca leaves buried with human remains and coca residue in storage vessels — dates to roughly 3000 BCE in what is now Peru and Bolivia. Coca chewing was embedded in the religious, social, and practical life of Andean civilizations long before the Inca Empire formalized its cultivation and use.
Andean Use: The Original Pharmacology
In traditional Andean practice, coca leaves are chewed with an alkaline catalyst — typically lime or plant ash — which facilitates the release of cocaine and related alkaloids from the leaf. The effect is mild and sustained compared to purified cocaine: a gentle stimulation, suppression of altitude-induced fatigue and hypoxia symptoms, reduced hunger, and a degree of analgesia. Coca chewing at altitude is genuinely pharmacologically rational — the compounds in the leaf measurably improve oxygen utilization and reduce the symptoms of altitude sickness, which is why coca remains in widespread use in the Andes today and why attempts to eradicate its cultivation have consistently failed to account for its legitimate local utility.
The Inca managed coca cultivation through a state monopoly and reserved its use, at least officially, for religious ceremonies, the nobility, and soldiers on campaign — a system that recognized both its value and its potential for misuse. When the Spanish conquistadors arrived in the 16th century, they initially attempted to suppress coca use as a pagan practice, then reversed course when they realized that Indigenous laborers in the silver mines worked more productively and required less food when supplied with coca leaves. Commercial interest overrode moral objection, as it frequently does, and Spanish colonial authorities became significant facilitators of coca cultivation.
European Curiosity and the Problem of Extraction
Coca leaves were brought to Europe by Spanish colonizers and generated intermittent scientific curiosity for centuries, but they posed a practical problem: the active alkaloids degraded during the long sea voyage from South America, making dried leaves available in Europe far less potent than fresh leaves used in the Andes. European physicians and chemists who experimented with coca preparations often found them disappointing, and widespread interest did not develop until the isolation of the pure compound became possible.
That isolation was achieved by the German chemist Friedrich Gaedcke in 1855 and refined by Albert Niemann in 1860, who coined the name “cocaine” and noted in his doctoral dissertation that it produced a numbing sensation on the tongue. The purified compound was now available in a form that could be reliably standardized, shipped, and administered — and which was dramatically more potent than the leaf preparations that had generated modest interest in preceding centuries. Purification transformed cocaine from a botanical curiosity into a pharmacological event.
The Medical Embrace: 1860–1900
The medical profession’s initial response to purified cocaine was, by the standards of the time, scientifically reasonable. The drug had observable, reliable, and powerful effects. It elevated mood, suppressed fatigue, increased energy and confidence, and produced a subjective sense of well-being that was immediately perceptible to anyone who took it. These effects were real, and in the context of 19th-century medicine — which had very few compounds capable of producing reliable changes in mental state — they were genuinely impressive. The framework for evaluating addiction risk, long-term neurological consequence, and the distinction between acute symptom relief and durable therapeutic benefit was largely absent from the medical literature of the period.
Angelo Mariani and the Commercialization of Coca
Before Freud, before the medical mainstream fully engaged with cocaine, a Corsican entrepreneur named Angelo Mariani had already recognized the commercial potential of coca alkaloids and was extracting enormous profit from it. Mariani’s Vin Tonique Mariani, introduced in 1863, was a Bordeaux wine in which coca leaves had been macerated — the alcohol in the wine extracting the cocaine into solution. At the dose provided by a glass of Vin Mariani, the cocaine content was modest but pharmacologically active. Mariani was a gifted marketer who collected celebrity endorsements with impressive energy: Pope Leo XIII gave the product a gold medal and appeared on a promotional poster. Thomas Edison endorsed it. Ulysses S. Grant reportedly drank it while dictating his memoirs in the final months of his life. Queen Victoria was said to favor it. The product’s promotional materials ran to eighteen volumes of testimonials from royalty, heads of state, physicians, and artists.
Vin Mariani was the template for what followed. When an Atlanta pharmacist named John Pemberton developed a competing product in 1886 — Pemberton’s French Wine Coca, later reformulated as Coca-Cola — he was operating in a market that Mariani had demonstrated was enormous and enthusiastic. The original Coca-Cola formula contained cocaine from coca leaf extract. It was removed in 1903, when cocaine’s reputation had begun to shift. The decocainized coca leaf extract that provides Coca-Cola’s distinctive flavor remains an ingredient today, processed by a single licensed facility in the United States.
The Discovery of Local Anesthesia
Among cocaine’s medical applications, one proved genuinely revolutionary and has remained in modified form to the present day. In 1884, the Viennese ophthalmologist Carl Koller discovered that cocaine applied topically to the eye produced complete local anesthesia — a finding that transformed eye surgery, which had previously required patients to be physically restrained while fully conscious. Koller presented his findings at a medical conference in September 1884, and the discovery spread through the surgical community with extraordinary speed. Cocaine became the first effective local anesthetic in the history of medicine, enabling surgical procedures on the eye, nose, throat, and other sensitive structures that had previously been either impossible or agonizing.
This legitimate application drove an important part of cocaine’s medical legitimacy: the drug that produced local anesthesia was the same drug being promoted for internal use, and the two applications shared a veneer of scientific seriousness. The local anesthetic discovery was real medicine. Its proximity to cocaine’s other, far more dubious medical applications lent those applications a credibility they did not independently warrant. Synthetic local anesthetics — procaine, introduced in 1905, and its descendants — eventually replaced cocaine in most surgical applications, though cocaine remains in use as a topical anesthetic in certain ear, nose, and throat procedures to this day, the sole remaining legitimate medical application of the drug in most countries.
Freud and Cocaine: A Complicated History
Sigmund Freud’s relationship with cocaine is the most extensively analyzed episode in the drug’s medical history, partly because of who Freud became and partly because the episode illustrates, with unusual clarity, how a brilliant and intellectually serious person can be systematically wrong about a drug they are personally using. Freud was not a credulous fool misled by pharmaceutical marketing. He was a careful observer, a prolific writer, and a man who applied genuine intellectual effort to the question of what cocaine was and what it could do. He was also taking it himself, regularly, for several years — a circumstance that made truly objective evaluation essentially impossible.
“Über Coca” and Its Claims
Freud’s 1884 paper reviewed the existing literature on coca and cocaine, added his own clinical observations, and made a series of specific therapeutic claims. The most consequential was his recommendation of cocaine as a treatment for morphine addiction — the idea being that cocaine could substitute for morphine and then be withdrawn more easily. He had observed this in at least one patient. What he had not observed, because it had not yet become apparent, was that cocaine produced its own powerful dependence and that patients treated for morphine addiction with cocaine frequently developed cocaine addiction alongside or instead of it. His friend Ernst von Fleischl-Marxow, to whom Freud had recommended cocaine as a morphine substitute, became severely addicted to both drugs and died in 1891 at the age of 45.
Freud’s personal cocaine use, which he described in letters to his fiancée Martha Bernays with a candor that his biographers have found both illuminating and troubling, continued through the mid-1880s. He described the drug’s effects on his mood and productivity in terms that are recognizable to any modern pharmacologist: the euphoria, the increased energy, the sense that problems had become manageable. He does not appear to have developed a clinical addiction in the way that Fleischl-Marxow did, but his personal experience of the drug’s positive effects clearly shaped his assessment of its medical potential in ways that he did not fully acknowledge.
The Retreat and the Residue
Freud largely withdrew from cocaine advocacy by the late 1880s, as the drug’s addictive properties became undeniable in the medical literature and as his own research moved toward the foundations of psychoanalysis. He referred to his cocaine writings in later years with what his biographer Ernest Jones described as acute embarrassment. The episode did not fundamentally damage his subsequent career — psychoanalysis would make him famous on entirely different grounds — but it remains a significant illustration of the limits of self-experimentation as a basis for therapeutic recommendation, and of the way that a drug’s acute pleasurable effects can overwhelm a clinician’s capacity for objective assessment when that clinician is also a user.
What Cocaine Actually Does to the Brain
The neurochemical mechanism of cocaine was not understood in Freud’s time and was not fully characterized until the latter half of the 20th century. Cocaine is a potent monoamine reuptake inhibitor: it blocks the transporters that normally remove dopamine, norepinephrine, and serotonin from the synaptic cleft after they have been released, causing these neurotransmitters to accumulate and their signals to be amplified and prolonged. The effect on dopamine in the nucleus accumbens — the brain’s primary reward circuit — is particularly powerful and is responsible for cocaine’s intensely pleasurable and reinforcing effects.
The Reward Circuit and Addiction
The nucleus accumbens is the brain region most directly associated with reward, motivation, and the reinforcement of behavior. Under normal circumstances, it responds to natural rewards — food, sex, social connection — with moderate dopamine release that motivates the repetition of rewarding behavior. Cocaine produces dopamine flooding in this region at a magnitude that natural rewards cannot approach, creating a reinforcement signal of extraordinary strength. The brain adapts to this flooding by downregulating dopamine receptors and reducing baseline dopamine activity — meaning that after repeated cocaine use, normal pleasures produce less reward than before, and the drug is needed just to reach a baseline of normal function. This is the neurological architecture of addiction, and it explains why cocaine dependence develops rapidly and is so difficult to reverse.
This mechanism was entirely opaque to 19th-century physicians. They observed that cocaine made people feel better and that patients wanted more of it. The framework for understanding why — and for understanding that the wanting was not a sign of efficacy but of dependence — did not exist. What looked like therapeutic success was in many cases the beginning of a pathological process, but the tools to distinguish between the two were not available to the physicians prescribing it.
The Cardiovascular and Neurological Risks
Beyond addiction, cocaine poses serious cardiovascular risks that were also invisible to its early medical advocates. Cocaine causes vasoconstriction — the narrowing of blood vessels — and increases heart rate and blood pressure simultaneously. In the coronary arteries, this combination can trigger vasospasm, reduced blood flow, and myocardial infarction even in young people with no prior cardiac history. Cocaine is a leading cause of drug-related cardiac events in emergency medicine today. It can also produce seizures, stroke, and a range of psychiatric effects including paranoia and cocaine-induced psychosis with extended use. None of these risks were apparent from the short-term clinical observations that formed the basis for cocaine’s medical legitimacy in the 1880s and 1890s.
The Fall: From Medicine to Menace
Cocaine’s medical reputation collapsed in the 1890s and 1900s under the weight of accumulating evidence of addiction and harm, combined with a set of political and social dynamics that accelerated regulation in ways that were not always driven purely by scientific concern.
The Addiction Literature
By the mid-1890s, the medical literature had begun to fill with accounts of cocaine dependence that were impossible to reconcile with the drug’s therapeutic framing. Physicians who had prescribed cocaine freely were now reporting patients who had lost control of their use, who were experiencing paranoia and physical deterioration, and who were unable to stop despite wanting to. The clinical picture of cocaine addiction — distinct from, and in some ways more complex than, opiate addiction — was being assembled from case reports across the American and European medical literature. The drug that had been promoted for treating morphine addiction turned out to be capable of producing an addiction of its own that was at least as severe.
Race, Politics, and the Harrison Act
The political path to cocaine regulation in the United States was shaped by forces beyond medical evidence. The early 20th century saw the deliberate amplification of racist narratives about cocaine use among Black Americans in the South — newspaper accounts, often fabricated or wildly exaggerated, claiming that cocaine made Black men violent, impervious to pain, and dangerous to white women. These claims were medically baseless and historically shameful, but they were politically effective, and they drove public and legislative pressure for cocaine restriction that was racially motivated at its root. The Harrison Narcotics Tax Act of 1914, which effectively criminalized non-medical cocaine use in the United States, was passed in a political environment saturated with these narratives. The legitimate medical case for cocaine restriction — the addiction literature, the cardiovascular risks, the psychiatric complications — was real and sufficient on its own merits. The political momentum behind regulation was driven by something uglier.
The Enduring Legacy
Cocaine’s trajectory from Andean sacred plant to Vin Mariani to Freud’s therapeutic enthusiasm to Schedule II controlled substance captures something important about how medical legitimacy works and how it fails. The drug’s acute effects were real, observable, and genuinely impressive by any standard — 19th-century or modern. The framework for evaluating those effects — for distinguishing between temporary symptom relief and lasting benefit, between patient satisfaction and patient welfare, between a drug’s effects and its costs — was inadequate to the task. The physicians who prescribed cocaine were not uniquely credulous or careless by the standards of their time. They were operating without the tools, the trial methodology, the neurochemical understanding, and the long-term follow-up data that would have shown them what they were actually doing.
Freud’s “brilliant future” prediction for cocaine was not irrational given what he knew in 1884. It was wrong, and it was wrong in ways that caused genuine harm to genuine people, including people he cared about. But the error was made in the dark, not in the light of available evidence that was being ignored. That distinction matters — not to excuse the harm, but to understand it accurately, which is the only basis on which the same kind of error can be avoided in the future.
The single surviving legitimate medical use — cocaine as a topical anesthetic in certain ENT procedures — is a fitting remnant. The drug does have a pharmacological property that is genuinely useful and that synthetic alternatives have not entirely replaced: it is the only local anesthetic that also produces vasoconstriction, which reduces bleeding in nasal surgery. That narrow, specific, topically applied utility was always real. It was the extrapolation from that reality into a comprehensive theory of cocaine as a brain medicine that was the error — the assumption that a drug capable of producing a powerful short-term effect must therefore be capable of producing lasting therapeutic benefit. It is an assumption that has been made about many drugs before and since. It is still being made today.
The Brain in History and Culture: Full Series
- Ancient Nootropics: What Egyptian, Greek, and Chinese Physicians Prescribed for Mental Acuity
- The History of Coffee — How the Most Widespread Cognitive Enhancer in History Changed Civilization
- Phrenology and Why Smart People Believed It for 150 Years
- The Lobotomy Era: How a Nobel Prize Was Awarded for One of Medicine’s Greatest Disasters
- How Soldiers in World War II Were Given Amphetamines As Standard Issue — and the Aftermath
- The History of Cocaine as a Legitimate Brain Medicine (and Freud’s Role in It) — You are here
- How the Discovery of Neurons Changed Everything We Thought We Knew About the Mind
- The Victorian Obsession With the Electric Brain — Early Attempts at Brain Stimulation